Original news and analysis on international IP policy
The French Ministry of Social Affairs and Health announced today that the ministry has negotiated with pharmaceutical company Gilead to bring down the prices of hepatitis C medicines.
A partnership of government agencies and organisations in the United States and United Kingdom have announced an investment of up to US$48 million into the development of new antibiotics and products to fight antibiotic resistant bacteria, with the aim of having two new antibiotics in human trials in the next five years.
A range of civil society organisations today issued a letter to European Union leadership urging support for a World Health Organization resolution that mandates a feasibility study on a fund for cancer research and development that delinks R&D costs from the price of health technologies.
Public health group Médecins Sans Frontières (MSF) announced today that it has joined civil society organisations from 17 countries in Europe in filing a patent challenge at the European Patent Office to Gilead’s patent on sofosbuvir, an important treatment for hepatitis C.
The situation with IP rights in Russia is steadily deteriorating, which is mainly due to the recently imposed restrictions for foreign biopharmaceutical companies to participate in public procurement procedures in Russia, the encouragement of parallel imports, as well as the increased consumption of pirated software, according to recent statements of the Russian Ministry of Industry and Trade and local analysts in the field of IP protection.
European Patent Office President Benoît Battistelli today in Brussels expressed confidence that the first European Union unitary patent could be granted by the end of this year despite continued delays in the ratification process.But doubts remain.
Representatives of the research and academic community applauded amendments by the rapporteur to the draft new European Union Copyright Directive in yet another hearing on the megaproject yesterday in Brussels. Especially welcomed was the rapporteur's proposal to extend the scope of an exemption for text and data mining. Representatives of publishers, on the other hand, said there is no evidence of the need for additional mandatory exemptions.
The European Parliament announced today that its Legal Affairs Committee approved new draft legislation to bring European Union law into line with an international treaty providing copyright exceptions for special format books for visually impaired people. Limitations to the scope of the treaty, such as commercial availability or compensation, were disregarded by Parliament members.
As negotiations take place this week, an evaluation of the impact of one of the TRIPS-plus measures of the Mercosur/EU FTA on the prices of medicines in Brazil has been released. Based on the draft of the agreement, by their calculations, an additional USD 444 million would be necessary to be spent by the public health system for the purchase of six medicines alone, write Marcela Fogaça Vieira and Gabriela Costa Chaves.
At the world‘s biggest computer fair, the CEBIT in Hannover, Germany today, an official of the European Patent Office promoted patents for computer-implemented inventions (CII), also called software patents by critics. CII continues to grow considerably, according to EPO.
The report from a meeting of a World Health Organization informal advisory group on challenges of medicines pricing and organising a Fair Pricing Forum this spring has been made public. The report shows the analysis and assertions of the diverse group, as well as questions and plans to take forward.
As the ratification by the European Union of an international treaty creating an exception to copyright for visually impaired people nears, a leaked text shows that the directive implementing the treaty in the EU might come with safeguards limiting the scope of the treaty, allegedly pushed by the publishing industry.